Bulk Manufacturer of Controlled Substances Application: Research Triangle Institute, 36947 [2019-16175]
Download as PDF
<![CDATA[
36947
Federal Register / Vol. 84, No. 146 / Tuesday, July 30, 2019 / Notices
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 30, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Research
Triangle Institute
ACTION:
Notice of application.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR
1301.33(a), this is notice that on May 23,
2019, Research Triangle Institute, 3040
East Cornwallis Road, Hermann
Building, Room 106, Research Triangle
Park, North Carolina 27709, applied to
be registered as a bulk manufacturer of
the following basic class of controlled
substance:
Controlled substance
Drug code
Tetrahydrocannabinols ..........................................................................................................................................
The company will manufacture via
synthesis, Tetrahydrocannabinols (7370)
for use by customers as analytical
reference standards.
Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
Drug Enforcement Administration
[Docket No. DEA–392]
[FR Doc. 2019–16175 Filed 7–29–19; 8:45 am]
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 30, 2019.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR
1301.33(a), this is notice that on March
18, 2019, AMPAC Fine Chemicals LLC,
Highway 50 and Hazel Avenue,
Building 05001, Rancho Cordova,
California 95670 applied to be registered
as bulk manufacturer of the following
basic classes of controlled substances:
Controlled substance
Drug code
Methylphenidate .....................................................................................................................................................
Levomethorphan ....................................................................................................................................................
Levorphanol ...........................................................................................................................................................
Thebaine ................................................................................................................................................................
Tapentadol .............................................................................................................................................................
Remifentanil ...........................................................................................................................................................
The company plans to manufacture
the listed controlled substances for
distribution to its customers.
Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–16177 Filed 7–29–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
jspears on DSK3GMQ082PROD with NOTICES
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Southern Ohio
Correctional Facility
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class, and applicants
DATES:
VerDate Sep<11>2014
16:42 Jul 29, 2019
Jkt 247001
therefore, may file written comments on
or objections to the issuance of the
proposed registration or the proposed
authorization to import on or before
August 29, 2019. Such persons may also
file a written request for a hearing on
the application for registration and for
authorization to import on or before
August 29, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
a should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
I
ADDRESSES:
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: AMPAC Fine
Chemicals LLC
BILLING CODE 4410–09–P
7370
Schedule
1724
9210
9220
9333
9780
9739
Schedule
II
II
II
II
II
II
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
Pursuant to 21 U.S.C. 958(i), prior to
issuing a regulation under 21 U.S.C.
952(a)(2)(B) authorizing the importation
of a controlled substance in schedule I
or II, DEA is required to provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Additionally, pursuant to 21 CFR
1301.34(a), DEA shall, upon the filing of
an application for registration to import
a controlled substance in schedule I or
II under 21 U.S.C. 952(a)(2)(B), provide
notice and the opportunity to request a
hearing to manufacturers holding
registrations for the bulk manufacture of
the substance and to applicants for such
registrations.
E:\FR\FM\30JYN1.SGM
30JYN1
]]>Agencies
[Federal Register Volume 84, Number 146 (Tuesday, July 30, 2019)]
[Notices]
[Page 36947]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-16175]
[[Page 36947]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Research
Triangle Institute
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before September 30, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on May
23, 2019, Research Triangle Institute, 3040 East Cornwallis Road,
Hermann Building, Room 106, Research Triangle Park, North Carolina
27709, applied to be registered as a bulk manufacturer of the following
basic class of controlled substance:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols............ 7370 I
------------------------------------------------------------------------
The company will manufacture via synthesis, Tetrahydrocannabinols
(7370) for use by customers as analytical reference standards.
Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-16175 Filed 7-29-19; 8:45 am]
BILLING CODE 4410-09-P
